• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form 10-K/A filed by Research Frontiers Incorporated

    4/15/25 6:05:34 PM ET
    $REFR
    Multi-Sector Companies
    Miscellaneous
    Get the next $REFR alert in real time by email
    true FY 0000793524 0000793524 2023-01-01 2023-12-31 0000793524 2023-06-30 0000793524 2024-03-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

      REFR

    Amendment No. 1 to 

    FORM 10-K/A

     

    ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) of

    THE SECURITIES AND EXCHANGE ACT OF 1934

     

    For the fiscal year ended December 31, 2023 Commission File Number 1-9399

     

    RESEARCH FRONTIERS INCORPORATED

    (Exact name of registrant as specified in its charter)

     

    delaware   11-2103466
    (State or other jurisdiction of   (I.R.S. Employer
    incorporation or organization)   Identification No.)
         
    240 CROSSWAYS PARK DRIVE    
    WOODBURY, new york   11797-2033
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code (516) 364-1902

     

    Securities registered pursuant to Section 12(b) of the Act:  
         
    Title of Class  

    Name of Exchange on Which Registered

    Common Stock, $0.0001 Par Value   The NASDAQ Stock Market

     

    Securities registered pursuant to Section 12(g) of the Act: None

     

    Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

     

    Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

     

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

     

    Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

     

    Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☒

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

     

    Large accelerated filer ☐   Accelerated filer ☐   Non-accelerated filer ☐

     

    Smaller reporting company ☒   Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

    Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared its audit report. ☐

     

    If the securities registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

     

    Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to Section 240.10D-1(b). ☐

     

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

     

    The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2023 (the last business day of the registrant’s most recently completed second fiscal quarter), computed based on the closing sale price of $1.60 was $51,773,808. In making this computation, all direct and indirect shares known to be owned by directors and executive officers of the Company and all direct and indirect shares known to be owned by other persons holding in excess of 5% of the Company’s common stock have been deemed held by “affiliates” of the Company, and awards of restricted stock subject to vesting are assumed to have been fully issued and outstanding. Nothing herein shall prejudice the right of the Company or any such person to deny that any such director, executive officer, or stockholder is an “affiliate.”

     

    On March 7, 2024, the registrant had 33,509,287 shares of Common Stock outstanding.

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This Amendment No. 1 on Form 10-K/A (this “Amendment”) is being filed by Research Frontiers Incorporated (the “Company”) to amend its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, originally filed with the Securities and Exchange Commission (“SEC”) on March 7, 2024 (the “Original Filing”).

     

    This Amendment is being filed solely to include the Company’s Executive Compensation Recovery (Clawback) Policy, adopted in accordance with SEC Rule 10D-1 and NASDAQ Listing Rule 5608, which was inadvertently omitted from the Original Filing. The policy is filed as Exhibit 97 to this Amendment.

     

    No other changes have been made to the Original Filing. The Company is not aware of any event that would trigger the application of the Executive Compensation recovery (Clawback) Policy. This Amendment does not reflect events occurring after the filing of the Original Filing and does not modify or update the disclosures therein in any way, other than as specifically set forth herein.

     

    PART IV

     

    ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

     

    The following exhibit is filed as part of this Amendment No. 1 to the Company’s Annual Report on Form 10-K:

     

    Exhibit 97 – Executive Compensation Recovery (Clawback) Policy effective as of October 2, 2023. (filed herewith)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      RESEARCH FRONTIERS INCORPORATED
      (Registrant)
       
      /s/ Joseph M. Harary
      Joseph M. Harary, President, CEO and Acting Interim CFO
      (Principal Executive Officer and Principal Financial and Accounting Officer)

     

    Dated: April 15, 2025

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

     

    Signature   Position   Date
             
    /s/ Darryl Daigle   Director April 15, 2025
    Darryl Daigle        
             
    /s/ Joseph M. Harary   Director, President, CEO and Acting Interim CFO April 15, 2025
    Joseph M. Harary        
             
    /s/ Alexander Kaganowicz   Director April 15, 2025
    Alexander Kaganowicz        
             
    /s/ Eyal Peso   Director April 15, 2025
    Eyal Peso        

     

     

     

    Get the next $REFR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $REFR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $REFR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by VP-Marketing Lapointe Michael R

      4 - RESEARCH FRONTIERS INC (0000793524) (Issuer)

      1/2/25 6:48:01 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • SEC Form 4 filed by President and CEO Harary Joseph M

      4 - RESEARCH FRONTIERS INC (0000793524) (Issuer)

      1/2/25 6:48:02 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • SEC Form 4 filed by Director Daigle Darryl

      4 - RESEARCH FRONTIERS INC (0000793524) (Issuer)

      1/2/25 6:48:00 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous

    $REFR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Research Frontiers Incorporated

      SC 13G - RESEARCH FRONTIERS INC (0000793524) (Subject)

      1/25/24 9:15:55 AM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • SEC Form SC 13G filed by Research Frontiers Incorporated

      SC 13G - RESEARCH FRONTIERS INC (0000793524) (Subject)

      10/19/23 3:59:29 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • SEC Form SC 13G/A filed by Research Frontiers Incorporated

      SC 13G/A - RESEARCH FRONTIERS INC (0000793524) (Subject)

      3/15/21 4:15:32 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous

    $REFR
    SEC Filings

    See more
    • SEC Form 10-Q filed by Research Frontiers Incorporated

      10-Q - RESEARCH FRONTIERS INC (0000793524) (Filer)

      5/8/25 4:01:43 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • SEC Form DEF 14A filed by Research Frontiers Incorporated

      DEF 14A - RESEARCH FRONTIERS INC (0000793524) (Filer)

      4/30/25 4:01:23 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • Amendment: SEC Form 10-K/A filed by Research Frontiers Incorporated

      10-K/A - RESEARCH FRONTIERS INC (0000793524) (Filer)

      4/15/25 6:05:34 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous

    $REFR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Kaganowicz Alexander bought $3,880 worth of shares (2,000 units at $1.94), increasing direct ownership by 1% to 164,923 units (SEC Form 4)

      4 - RESEARCH FRONTIERS INC (0000793524) (Issuer)

      6/17/24 6:30:05 AM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • Daigle Darryl bought $7,482 worth of shares (4,300 units at $1.74) (SEC Form 4)

      4 - RESEARCH FRONTIERS INC (0000793524) (Issuer)

      6/10/24 6:04:49 AM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • Daigle Darryl bought $1,000 worth of shares (1,000 units at $1.00) (SEC Form 4)

      4 - RESEARCH FRONTIERS INC (0000793524) (Issuer)

      2/8/24 5:50:48 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous

    $REFR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Research Frontiers Reports First Quarter 2025 Financial Results and Will Host a Conference Call at 4:30p.m. Today

      WOODBURY, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter of 2025. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.  •Who: Joseph M. Harary, President & CEO •Date/Time: Thursday, May 8, 2025, 4:30 PM ET •Dial-in Information:1-888-334-5785 •Conference Link: https://join.broaddata.com/?id=research-frontiers •Replay: Available on Friday, May 9, 2025 for 90 days at https://smartglass-ir.com Key Comments: 1.Strong Revenue Growth in the Automotive and Aircraft MarketsResearch Frontiers royalty income increased by

      5/8/25 4:01:00 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • RESEARCH FRONTIERS TO HOST FIRST QUARTER 2025 CONFERENCE CALL

      WOODBURY, NY, May 05, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025. Research Frontiers will host a conference call at 4:30 p.m. Eastern Time on Thursday, May 8, 2025 to discuss its first quarter 2025 financial and operating results, as well as recent developments. Who: Joseph M. Harary, President & CEODate/Time: Thursday, May 8, 2025, 4:30 PM ETDial-in Information: 1-888-334-5785Conference Link: https://join.broaddata.com/?id=research-frontiersQuestions: Email to [email protected]: Available on Friday, May 9, 2025 for 90 days at https://smartglass-ir.com/

      5/5/25 8:30:00 AM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • Gauzy's State-of-The-Art Smart Glass Technologies Utilized in the Mercedes-Benz Vision V Show Car, Unveiled at Auto Shanghai 2025

      Mercedes-Benz Chooses Gauzy's Dual Smart Glass Technology Stack, Combining both SPD & PDLC, Highlighting the Evolution of Automotive Smart Glass Integration by Mercedes-Benz. Approximately 75% of the Show Cars' Vehicle Glazing Includes Gauzy's Dual Smart Glass Stack, Showcasing the Widespread Applications and Benefits of this Technology When Used Throughout a Vehicle. Solidifies Mercedes-Benz and Gauzy's Continued Partnership, and Underscores Mercedes-Benz's Commitment to Bring State-of-the-Art Technologies into Innovative Show Cars. Photo Credit: Mercedes-Benz TEL AVIV, Israel, April 23, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ:GAUZ), a global leader in light and vision control t

      4/23/25 7:30:00 AM ET
      $GAUZ
      $REFR
      Industrial Machinery/Components
      Miscellaneous
      Multi-Sector Companies

    $REFR
    Leadership Updates

    Live Leadership Updates

    See more
    • Eyal Peso, CEO of Smart Materials Company Gauzy, Ltd. Joins Board of Directors of Smart Glass Leader Research Frontiers

      Woodbury, New York and Tel Aviv/Jaffo, June 05, 2023 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (NASDAQ:REFR) and Gauzy Ltd. announced today the appointment of Eyal Peso to the Research Frontiers Board of Directors effective June 4, 2023. Mr. Peso, age 43, is the Co-Founder, Chairman of the Board of Directors and CEO of smart materials manufacturer Gauzy, Ltd. Joseph M. Harary, President and CEO of Research Frontiers noted: "Eyal Peso has been a transformational force in our industry. From our first meeting, we shared the same vision of what the smart glass industry should become, and together we have worked hard, and have invested considerable resources, to bring the best performing

      6/5/23 8:30:00 AM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • PDS Biotechnology Appoints Seth Van Voorhees as Chief Financial Officer

      FLORHAM PARK, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced the appointment of Seth Van Voorhees, Ph.D. as its new Chief Financial Officer effective January 1, 2021. “Dr. Van Voorhees is a highly accomplished CFO with extensive experience in corporate finance, capital markets, investment banking and licensing. His appointment comes at a time of significant opportunity and growth for our Company. His business and financial expertise will be instrumental in

      12/9/20 8:30:00 AM ET
      $REFR
      $PDSB
      Multi-Sector Companies
      Miscellaneous
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $REFR
    Financials

    Live finance-specific insights

    See more
    • Research Frontiers Reports First Quarter 2025 Financial Results and Will Host a Conference Call at 4:30p.m. Today

      WOODBURY, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter of 2025. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.  •Who: Joseph M. Harary, President & CEO •Date/Time: Thursday, May 8, 2025, 4:30 PM ET •Dial-in Information:1-888-334-5785 •Conference Link: https://join.broaddata.com/?id=research-frontiers •Replay: Available on Friday, May 9, 2025 for 90 days at https://smartglass-ir.com Key Comments: 1.Strong Revenue Growth in the Automotive and Aircraft MarketsResearch Frontiers royalty income increased by

      5/8/25 4:01:00 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • RESEARCH FRONTIERS TO HOST FIRST QUARTER 2025 CONFERENCE CALL

      WOODBURY, NY, May 05, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025. Research Frontiers will host a conference call at 4:30 p.m. Eastern Time on Thursday, May 8, 2025 to discuss its first quarter 2025 financial and operating results, as well as recent developments. Who: Joseph M. Harary, President & CEODate/Time: Thursday, May 8, 2025, 4:30 PM ETDial-in Information: 1-888-334-5785Conference Link: https://join.broaddata.com/?id=research-frontiersQuestions: Email to [email protected]: Available on Friday, May 9, 2025 for 90 days at https://smartglass-ir.com/

      5/5/25 8:30:00 AM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • Research Frontiers Reports 2024 Financial Results and Will Host a Conference Call at 4:30p.m. Today

      WOODBURY, N.Y., March 06, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its fourth quarter and full-year 2024. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.  •Who: Joseph M. Harary, President & CEO •Date/Time: Thursday, March 6, 2025, 4:30 PM ET •Dial-in Information:1-888-334-5785 •Replay: Available on Friday, March 7, 2025 for 90 days at https://smartglass-ir.com/    Key Comments: 1.Revenue Growth in the Automotive and Aircraft MarketsResearch Frontiers royalty income increased by 47% in 2024 to $1,335,531 compared to $909,598 in 202

      3/6/25 4:01:00 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous